Your session is about to expire
← Back to Search
Balloon dilation of the eustachian tube for Eustachian Tube Dysfunction (BDET Trial)
BDET Trial Summary
This trial is testing two treatments for eustachian tube dysfunction: balloon dilation and nasal saline. Patients will be followed for a year, and can switch treatments after 3 months if they want.
- Eustachian Tube Dysfunction
BDET Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowBDET Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BDET Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You currently have problems with your jaw joint that are causing pain or dysfunction.You have cystic fibrosis, ciliary dysmotility syndrome, or a weakened immune system.Your nasal passages have blockages or structural abnormalities that would make it difficult to access the Eustachian tube through your nose.You have a birth defect called cleft palate or a condition called craniofacial syndrome affecting the face and head.You currently have a bad cold or flu.You have a condition called patulous eustachian tube.You have had previous procedures done on your eustachian tubes.You currently have a severe ear infection.You have a long-lasting ear infection with a growth called cholesteatoma.You have ongoing sinusitis, allergies, or acid reflux that isn't getting better with medication.You have received radiation treatment to your head and neck area in the past.You have been diagnosed with ongoing ear tube blockage for at least 3 months before joining the study, either in one or both ears.You have a small tube in your ear or a hole in your eardrum.You have problems with your hearing that come and go or you have been diagnosed with Meniere's disease.
- Group 1: Eustachian tube dilation
- Group 2: Control Group
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is recruitment for this study ongoing?
"Per clinicaltrials.gov, the participants for this medical trial are being actively recruited right now. The first post was made on February 24th 2022 and last modified a day later."
What is the aggregate of individuals participating in this clinical experiment?
"Yes, the details available on clinicaltrials.gov support that this investigation is presently inviting applications from participants. This medical research was initially posted on February 24th 2022 and last modified on February 25th 2022. Approximately 58 individuals are required for this trial at a single location."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger